In September 2012, Vitalea Science was acquired by Eckert & Ziegler and renamed Eckert & Ziegler Vitalea Science, Inc. operating as a subsidiary of Eckert & Ziegler Isotope Products, Inc. Vitalea Science had been a contract research organization providing ultra-sensitive detection strategies for drugs and drug candidates at microdose levels. Formed by chemists and physicists from the University of California, Davis, Vitalea's scientists have expertise in Accelerator Mass Spectrometry (AMS) technology exploring the pharmacokinetics and metabolism of drug candidates directly in humans, prior to - and as part of Phase I clinical trials. The firm offers ultra-sensitive detection strategies for drugs and drug candidates at microdose levels; and services in the areas of traditional radioanalysis, validated UPLC for rapid profiling, quality assurance, absolute bioavailability studies,
